During the past decade, CEN-Consultorios Especializados en Neurociencias conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CEN-Consultorios Especializados en Neurociencias" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "H. Lundbeck A/S" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "CEN-Consultorios Especializados en Neurociencias" are "Schizophrenia" (5 trials), "Depressive Disorder, Major" (4 trials), "Alzheimer Disease" (2 trials), "Borderline Personality Disorder" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "CEN-Consultorios Especializados en Neurociencias" in a lesser frequency.

Most popular intervention types in "CEN-Consultorios Especializados en Neurociencias" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Gantenerumab" (2 trials), "Pimavanserin" (2 trials), "SSRI/SNRI" (2 trials) and "Aticaprant" (1 trials). Other intervention names were less common.

The vast majority of trials in "CEN-Consultorios Especializados en Neurociencias" are 13 trials for "All" genders.

Currently, there are NaN active trials in "CEN-Consultorios Especializados en Neurociencias". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CEN-Consultorios Especializados en Neurociencias, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CEN-Consultorios Especializados en Neurociencias, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".